Testing version — LOERadar is in active testing. Features and data may change.
CARBIDOPA AND LEVODOPA (CARBIDOPA, LEVODOPA) | LOERadar
Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
CARBIDOPA AND LEVODOPA
ANDATentative Approval
CARBIDOPA, LEVODOPA | A219231 | DR REDDYS LABS LTD
Products (7)
Sort:
#002 — 145MG
▴
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00
No patent or exclusivity listings for this strength.
#003 — 23.75
▾
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00
#004 — 95MG
▾
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00
#005 — 245MG
▾
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00
#006 — 61.25MG
▾
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00
#007 — 48.75MG
▾
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00
#008 — 195MG
▾
CAPSULE, EXTENDED RELEASE | TA Date: 2025-06-13 00:00:00